SCHEMBL8775965

SCHEMBL8775965

C[C@@H]1Cc2cc(O)ccc2[C@@H]2[C@@H]1[C@@H]1CC[C@@](O)(O[N+](=O)[O-])[C@@]1(C)C[C@@]2(O)O[N+](=O)[O-]

nearest known ligand 0.34

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
STS P08842 7/20 0.34
ESR1 P03372 7/20 0.33
ESR2 Q92731 5/20 0.33
CYP3A4 P08684 3/20 0.32
ABCB11 O95342 2/20 0.32
SHBG P04278 2/20 0.32
PGR P06401 2/20 0.32
AR P10275 2/20 0.32
SLC6A4 P31645 2/20 0.32
OPRM1 P35372 2/20 0.32
HTR2B P41595 2/20 0.32
SLC6A3 Q01959 2/20 0.32
SLC22A2 O15244 1/20 0.32
NR1I2 O75469 1/20 0.32
NR3C1 P04150 1/20 0.32
HTR1A P08908 1/20 0.32
ADORA3 P0DMS8 1/20 0.32
ADRB3 P13945 1/20 0.32
CYP2B6 P20813 1/20 0.32
TBXA2R P21731 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8775974 0.85 STS (0.43) STSESR1ESR2CYP3A4ABCB11
SCHEMBL3424817 0.83 STS (0.48) STSESR1ESR2CYP3A4ABCB11
SCHEMBL6540806 0.83 ESR1 (0.39) STSESR1ESR2CYP3A4ABCB11
SCHEMBL8776086 0.67 ESR1 (0.54) STSESR1ESR2CYP3A4ABCB11
SCHEMBL6257173 0.66 ESR1 (0.40) STSESR1ESR2CYP3A4ABCB11
SCHEMBL6257864 0.66 ESR1 (0.40) STSESR1ESR2CYP3A4ABCB11
SCHEMBL2066330 0.64 ESR1 (0.66) STSESR1ESR2CYP3A4ABCB11
SCHEMBL1657388 0.64 STS (0.47) STSESR1ESR2CYP3A4ABCB11
SCHEMBL2066331 0.64 ESR1 (0.66) STSESR1ESR2CYP3A4ABCB11
SCHEMBL5713538 0.64 ESR1 (0.66) STSESR1ESR2CYP3A4ABCB11

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0719276-B1 ORALLY ACTIVE DERIVATIVES OF 1,3,5(10)-ESTRATRIENE US HEALTH (US) 1997-11-26 EP claimed
US-5554603-A 11,17-DINITRATES; USE TO ACHIEVE ESTROGENIC EFFECT IN FEMALE MAMMALS THE UNITED STATES OF AMERICA AS REPRESENTED BY THE DEPARTMENT OF HEALTH AND HUMAN SERVICES (US) 1996-09-10 US claimed
WO-1995007925-A1 ORALLY ACTIVE DERIVATIVES OF 1,3,5(10)-ESTRATRIENE THE GOVERNMENT OF THE UNITED STATES OF AMERICA, REPRESENTED BY THE SECRETARY OF THE DEPARTMENT OF HEALTH AND HUMAN SERVICES (US) 1995-03-23 WO claimed
EP-0719276-B1 ORALLY ACTIVE DERIVATIVES OF 1,3,5(10)-ESTRATRIENE US HEALTH (US) 1997-11-26 EP disclosed
US-5554603-A 11,17-DINITRATES; USE TO ACHIEVE ESTROGENIC EFFECT IN FEMALE MAMMALS THE UNITED STATES OF AMERICA AS REPRESENTED BY THE DEPARTMENT OF HEALTH AND HUMAN SERVICES (US) 1996-09-10 US disclosed
WO-1995007925-A1 ORALLY ACTIVE DERIVATIVES OF 1,3,5(10)-ESTRATRIENE THE GOVERNMENT OF THE UNITED STATES OF AMERICA, REPRESENTED BY THE SECRETARY OF THE DEPARTMENT OF HEALTH AND HUMAN SERVICES (US) 1995-03-23 WO disclosed